These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17175290)

  • 21. A comparison of plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody.
    Stegall MD; Gloor J; Winters JL; Moore SB; Degoey S
    Am J Transplant; 2006 Feb; 6(2):346-51. PubMed ID: 16426319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of immunity and inflammation by intravenous immunoglobulin: relevance to solid organ transplantation.
    Jordan SC; Toyoda M; Vo AA
    Expert Rev Clin Immunol; 2011 May; 7(3):341-8. PubMed ID: 21595600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic strategies in management of the highly HLA-sensitized and ABO-incompatible transplant recipients.
    Jordan SC; Peng A; Vo AA
    Contrib Nephrol; 2009; 162():13-26. PubMed ID: 19001810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Failure of anti-CD20 monoclonal antibody therapy to prevent antibody-mediated rejection in three crossmatch-positive renal transplant recipients.
    Matignon M; Tagnaouti M; Audard V; Dahan K; Lang P; Grimbert P
    Transplant Proc; 2007 Oct; 39(8):2565-7. PubMed ID: 17954175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can intravenous immunoglobulin and simvastatin solve the problem of sensitization in renal transplant candidates?
    Mahmoud KM; Sobh MA; El-Shenawy F; Isamil AM; El-Magd MA; Hassan NA; El-Agroudy AE; Sheashaa HA; Opelz G; Ghoneim MA
    Int Urol Nephrol; 2007; 39(3):979-81. PubMed ID: 17541722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute renal transplant injury and interaction between antithymocyte globulin and pooled human immunoglobulin.
    Gallay BJ; Perez RV; Ramsamooj R
    Clin Transplant; 2004 Jun; 18(3):327-31. PubMed ID: 15142056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Restoration of humoral immunity after intravenous immunoglobulin replacement therapy in heart recipients with post-transplant antibody deficiency and severe infections.
    Carbone J; Sarmiento E; Del Pozo N; Rodriguez-Molina JJ; Navarro J; Fernandez-Yañez J; Palomo J; Villa A; Muñoz P; Fernandez-Cruz E
    Clin Transplant; 2012; 26(3):E277-83. PubMed ID: 22686951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ABO incompatible renal transplantation in an HIV-seropositive patient.
    Campara M; West-Thielke P; Thielke J; Ommert T; Oberholzer J; Benedetti E; Kaplan B
    Transplantation; 2008 Jul; 86(1):176-8. PubMed ID: 18622297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rituximab and intravenous immunoglobulin treatment of chronic antibody-mediated kidney allograft rejection.
    Fehr T; Rüsi B; Fischer A; Hopfer H; Wüthrich RP; Gaspert A
    Transplantation; 2009 Jun; 87(12):1837-41. PubMed ID: 19543061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of the sensitized cardiac recipient: the use of plasmapheresis and intravenous immunoglobulin.
    Leech SH; Lopez-Cepero M; LeFor WM; DiChiara L; Weston M; Furukawa S; Macha M; Singhal A; Wald JW; Nikolaidis LA; McClurken JB; Bove AA
    Clin Transplant; 2006; 20(4):476-84. PubMed ID: 16842525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical relevance of Luminex donor-specific crossmatches: data from 165 renal transplants.
    Billen EV; Christiaans MH; van den Berg-Loonen EM
    Tissue Antigens; 2009 Sep; 74(3):205-12. PubMed ID: 19497037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a 3-year follow-up.
    Genberg H; Kumlien G; Wennberg L; Berg U; Tydén G
    Transplantation; 2008 Jun; 85(12):1745-54. PubMed ID: 18580466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Value of donor-specific antibody detection in first-graft renal transplant recipients with a negative complement-dependent cytotoxic crossmatch.
    Mahmoud KM; Ismail AM; Sheashaa HA; Gheith OA; Kamal MM; Ghoneim MA
    Exp Clin Transplant; 2009 Jun; 7(2):124-8. PubMed ID: 19715518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of two different preconditioning regimens for ABO-incompatible living kidney donor transplantation. A comparison of splenectomy vs. rituximab-treated non-splenectomy preconditioning regimens.
    Tanabe K; Ishida H; Shimizu T; Omoto K; Shirakawa H; Tokumoto T
    Contrib Nephrol; 2009; 162():61-74. PubMed ID: 19001814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of rhGH in vitro on donor-specific hyporesponsiveness in pediatric transplantation.
    Benfield MR; Vail A; Waldo FB; Bucy RP; Kohaut EC
    Pediatr Transplant; 1997 Aug; 1(1):90-7. PubMed ID: 10084793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The potential impact of substitutive therapy with intravenous immunoglobulin on the outcome of heart transplant recipients with infections.
    Carbone J; Sarmiento E; Palomo J; Fernandez-Yañez J; Muñoz P; Bouza E; Rodríguez-Molina J; Lanio N; Fernandez-Cruz E
    Transplant Proc; 2007 Sep; 39(7):2385-8. PubMed ID: 17889198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of neonatal hemochromatosis with exchange transfusion and intravenous immunoglobulin.
    Rand EB; Karpen SJ; Kelly S; Mack CL; Malatack JJ; Sokol RJ; Whitington PF
    J Pediatr; 2009 Oct; 155(4):566-71. PubMed ID: 19560784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.